Hepatitis c inhibitor peptides

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/81 (2006.01) A61K 38/07 (2006.01) A61K 38/08 (2006.01) A61K 38/55 (2006.01) A61P 31/14 (2006.01) C07K 1/10 (2006.01) C07K 5/10 (2006.01) C07K 5/107 (2006.01) C07K 7/06 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2336597

Formula (I) wherein a is 0 or 1; b is 0 or 1; Y is H or Cy, alkyl; B is H, an acyl derivative or a sulfonyl derivative; W is hydroxy or a N-substituted amino; or a pharmaceutically acceptable salt or ester thereof, for use in the treatment of hepatitis C virus (HCV) infection.

Peptides inhibiteurs de l'hépatite C ayant la formule (F) dans laquelle a est 0 ou 1; b est 0 ou 1; Y représente H ou alkyle C1-C6; B représente H, un dérivé acyle ou un dérivé sulfonyle; W représente hydroxy ou un amino N-substitué; ou un de leurs sels ou esters acceptables sur le plan pharmaceutique; ces peptides sont utiles dans le traitement d'une infection par le virus de l'hépatite C.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hepatitis c inhibitor peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hepatitis c inhibitor peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis c inhibitor peptides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1629236

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.